Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study.
about
Intensive glucose control versus conventional glucose control for type 1 diabetes mellitusWhy do some patients with type 1 diabetes live so long?Insulin sensitivity and complications in type 1 diabetes: New insightsCardiovascular complications of type 1 diabetes: update on the renal link.Influence of a family history of type 2 diabetes, demographic and clinical data on carotid intima-media thickness in patients with type 1 diabetes: a cross-sectional study.The relationship between proteinuria and coronary risk: a systematic review and meta-analysisRetinal vessel diameter and the incidence of coronary artery disease in type 1 diabetes.A randomized controlled trial of an internet-based mentoring program for type 1 diabetes patients with inadequate glycemic control.Lipoprotein-associated phospholipase A2, C-reactive protein, and coronary artery disease in individuals with type 1 diabetes and macroalbuminuria.Is glycaemia or insulin dose the stronger risk factor for coronary artery disease in type 1 diabetes?Leptin deficiency causes insulin resistance induced by uncontrolled diabetes.Lipoprotein subfraction cholesterol distribution is proatherogenic in women with type 1 diabetes and insulin resistance.Glycemic control and cardiovascular disease in 7,454 patients with type 1 diabetes: an observational study from the Swedish National Diabetes Register (NDR).Development of a coronary heart disease risk prediction model for type 1 diabetes: the Pittsburgh CHD in Type 1 Diabetes Risk Model.Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.Prevalence of systemic co-morbidities in patients with various grades of diabetic retinopathyApolipoprotein A-I mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a murine model of diabetes.Increase in GLUT1 in smooth muscle alters vascular contractility and increases inflammation in response to vascular injuryAssociations of dietary intake patterns identified using reduced rank regression with markers of arterial stiffness among youth with type 1 diabetes.Augmentation pressure and subendocardial viability ratio are associated with microalbuminuria and with poor renal function in type 1 diabetes.Predicting major outcomes in type 1 diabetes: a model development and validation studyMyocardial structure, function, and scar in patients with type 1 diabetes mellitus.Coronary artery calcifications predict long term cardiovascular events in non diabetic Caucasian hemodialysis patients.Coronary Atherosclerotic Plaque Detected by Computed Tomographic Angiography in Subjects with Diabetes Compared to Those without Diabetes.Association between apolipoprotein E polymorphism and subclinic atherosclerosis in patients with type 1 diabetes mellitus.Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus.Carotid intima-media thickness and arterial stiffness in type 1 diabetic patients with and without microangiopathy1H NMR metabonomics approach to the disease continuum of diabetic complications and premature deathType 2 diabetes mellitus and exercise impairmentArterial stiffness, lipoprotein particle size, and lipoprotein particle concentration in children with type 1 diabetesRelationship between risk factors and mortality in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study (PCS).Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetesSex-specific-differences in cardiometabolic risk in type 1 diabetes: a cross-sectional study.Interactions between microvascular and macrovascular disease in diabetes: pathophysiology and therapeutic implications.Dyslipidemia in youth with diabetes: to treat or not to treat?Early diabetic nephropathy: a complication of reduced insulin sensitivity in type 1 diabetes.The changing face of young-onset diabetes: type 1 optimism mellowed by type 2 concerns.A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes.Mitigating micro-and macro-vascular complications of diabetes beginning in adolescence.Macrovascular angiopathy in children and adolescents with type 1 diabetes.
P2860
Q24200376-E325BC6F-5AB6-4BF0-B1FF-14F5A9187276Q26858877-3247FAA8-36DC-4982-8639-1DCE53D173B7Q27000205-A18AF1F1-E458-49D9-A430-D511B1A9D8FDQ30239971-14E88155-A68C-4167-B5B1-5ABCF616679BQ30828241-246614F3-057C-49A3-B266-20B603926F6BQ33378672-D43B6CD7-5BDC-4AEB-97BF-D73227592D9AQ33400921-825BA800-E4E3-46C8-BCF2-B8C76BD56C41Q33612524-4B7804CA-28D0-4C6F-B342-9D614D56C92CQ33805731-6323E379-EBC6-44B6-889C-C69DAE261FB8Q33833060-FABA3C1D-C2C2-4AFF-ABBB-782CE1E34B38Q33930217-A88715D6-B5D3-4E40-B9D4-6A00C1E95D4DQ33930299-78F0EABD-704D-49F0-AB58-B1B4596CCBF4Q33932860-5C43F99C-E37D-4E2A-A72E-0E4E9F5A467AQ33937293-0073AEEC-EB5C-4259-99B8-F84D5DFE1DD0Q34219439-A6C98138-B640-4C40-A765-77EAB0254F2EQ34272158-121B5254-1842-4E0A-A106-5BCFF3380541Q34355358-0D961D66-08AB-4FA5-B7DC-4D999BB00158Q34459819-1B234F98-A3D5-45A2-86D1-ABD63193C7ECQ34585518-EED08937-04E9-48B2-98CC-DFC74C47C864Q34618783-F49FF726-0A59-4E82-8BED-4C330F04F1B4Q35446651-CFBECB51-EBB6-4B74-BDB6-AA94C32D3129Q35548457-802CFE12-B316-402D-A428-85A00A8166DBQ35598557-69A4C284-EDBF-4B5F-9DDD-34FCEDCC9F56Q35850628-5C30B4B9-8334-4DB0-B3BB-EA43F6F41E59Q35862754-B4D022D8-A666-43A6-98AE-E56B44FFE1D2Q35910576-2960ED8A-75B2-45F7-A8A6-26567F9A7E44Q36105705-AD548290-859B-4897-B2F4-6BFAC31F0087Q36496258-FD8DB5F0-8204-456A-83A0-6CBFA7811015Q36673620-73B600CD-403A-4222-BB8C-C2E7056AAA83Q36714114-99DFBF3A-AED0-44BD-B953-85C8E8BEBDD3Q36756608-C1423065-09F1-4369-8711-0BDAE6814887Q36842641-534ECE59-FAD2-403E-BF72-C4A9672F6F20Q36884838-2667DB24-618E-445F-9CD0-317ADEEACE55Q36966063-D2723BCA-C157-4969-A90D-6FB5DE22E3FEQ36977819-9D4D4C33-5F41-4600-9617-94A42C437D08Q37278013-9AD3923B-E2BC-47B8-8E36-275C59BD8600Q37331253-3C56900B-E4EC-4796-91ED-58803FA50792Q37400773-4A8AA32C-6297-4E8C-A662-175EEF1562D9Q37458886-F37E00EE-DBEA-421B-BCEC-EEF4F4C927C3Q37857087-0DF637FA-D487-4A03-A8DD-B85A03135AC8
P2860
Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Risk factors for coronary hear ...... ospective Complications Study.
@en
Risk factors for coronary hear ...... ospective Complications Study.
@nl
type
label
Risk factors for coronary hear ...... ospective Complications Study.
@en
Risk factors for coronary hear ...... ospective Complications Study.
@nl
prefLabel
Risk factors for coronary hear ...... ospective Complications Study.
@en
Risk factors for coronary hear ...... ospective Complications Study.
@nl
P2093
P356
P1433
P1476
Risk factors for coronary hear ...... ospective Complications Study.
@en
P2093
Barry Ferriss
Christos Manes
EURODIAB Prospective Complications Study Group
Georges Michel
John H Fuller
Monika Toeller
Nish Chaturvedi
Paolo Reboldi
Sabita S Soedamah-Muthu
P304
P356
10.2337/DIACARE.27.2.530
P407
P577
2004-02-01T00:00:00Z